In breast cancer, the frequency of TP53 mutation is higher in carcinomas arising in a background of mutant BRCA1 and BRCA2 than in sporadic cases (Crook et al, 1997; Smith et al, 1999). The gene discussed is TP53; the disease is breast cancer.